Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for outpatient COVID-19
IRCT20160310026998N10Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of metformin in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Need for hospitalization, ARDS symptoms and 1 more. Started Mar 2020; status: completed.
02
Drugs
metformin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20160310026998N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160310026998N10.